Frequently Asked Questions about Genflow Biosciences plc (GENF.L)

Name: Genflow Biosciences plc (GENF.L) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Genflow Biosciences plc (GENF.L) do?

Accepted Answer

Genflow Biosciences plc operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing or halting the ageing process, and reducing the incidence of age-related diseases with increase in health span. Its lead compound is GF-100...

Question 2

Is Genflow Biosciences plc (GENF.L) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of GENF.L reveals an Altman Z-Score of -27.76 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if GENF.L fits their risk profile.

Question 3

What is the current P/E ratio for GENF.L?

Accepted Answer

As of the latest trading session, Genflow Biosciences plc (GENF.L) has a trailing P/E ratio of -5.91.

Question 4

Who is the CEO of Genflow Biosciences plc?

Accepted Answer

The current Chief Executive Officer of Genflow Biosciences plc is Eric Jean Leire.

Question 5

What was GENF.L's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Genflow Biosciences plc reported annual revenues of $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021), $0.00B (2021) respectively.

Question 6

Does GENF.L pay a dividend?

Accepted Answer

Genflow Biosciences plc does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does GENF.L have?

Accepted Answer

In its latest reporting period, Genflow Biosciences plc generated $-0.00B in Free Cash Flow against a total debt load of $N/A.

Question 8

What is the Price-to-Book (P/B) ratio of Genflow Biosciences plc?

Accepted Answer

The Price-to-Book (P/B) ratio for Genflow Biosciences plc (GENF.L) is currently -24.75.

Question 9

What is the Price-to-Sales (P/S) ratio of GENF.L?

Accepted Answer

Based on trailing twelve-month data, Genflow Biosciences plc (GENF.L) trades at a Price-to-Sales (P/S) ratio of -69.20.

Question 10

What is Genflow Biosciences plc's Return on Equity (ROE)?

Accepted Answer

Genflow Biosciences plc (GENF.L) has a Return on Equity (ROE) of 377.33%, representing its profitability relative to shareholder equity.